𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Potential role of high-field MRI for studies in Parkinson's disease

✍ Scribed by Norbert Schuff


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
284 KB
Volume
24
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Recent advancements in high field magnetic resonance imaging (MRI) technology (3 T and higher), providing increased signal sensitivity and images with more prominent contrasts intrinsic to the brain, offer new opportunities for assessing brain alterations in Parkinson's disease (PD). In this article, the principle benefits of high field MRI for PD research are described and new findings at high magnetic fields are reviewed. Several high field MRI methodologies, including structural MRI, imaging of brain iron, diffusion tensor imaging, arterial spin labeling perfusion imaging, rotating frame imaging, and magnetic resonance spectroscopy, are critically reviewed for their potential roles in studies of PD. Β© 2009 Movement Disorder Society


πŸ“œ SIMILAR VOLUMES


Formation of dopamine quinone-DNA adduct
✍ Muhammad Zahid; Muhammad Saeed; Li Yang; Cheryl Beseler; Eleanor Rogan; Ercole L πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 237 KB πŸ‘ 1 views

## Abstract The neurotransmitter dopamine is oxidized to its quinone (DA‐Q), which at neutral pH undergoes intramolecular cyclization by 1,4‐Michael addition, followed by oxidation to form leukochrome, then aminochrome, and finally neuromelanin. At lower pH, the amino group of DA is partially proto

Rationale for delayed-start study of pra
✍ Anthony H.V. Schapira; Stefan Albrecht; Paolo Barone; Cynthia L. Comella; Michae πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 112 KB

## Abstract Perhaps the most important unmet need in Parkinson's disease (PD) is the ability to slow or prevent progression of the neurodegeneration that underlies the motor and nonmotor features of this disorder. Pramipexole, a dopamine agonist used for the symptomatic treatment of PD, has demonst

No definitive evidence for a role for th
✍ John Hardy πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 48 KB πŸ‘ 1 views

also be involved in the pathogenesis of neurodegenerative disorders such as PD. Most strikingly, there are strong in vitro data suggesting that copper interacts with ␣-synuclein, which is thought to play a key role in the pathogenesis of PD. 2 Therefore, we examined the prevalence of the most freque